Sage Journals: Discover world-class research

Open access

Review article

First published 2009

Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc

Olga Latinovic, Janaki Kuruppu, Charles Davis [...]

Clinical Medicine Insights: Therapeutics

Free access

Review article

First published 2005-12

CCR5 Antagonists: Host-Targeted Antivirals for the Treatment of HIV Infection

Mike Westby, Elna van der Ryst

Antiviral Chemistry and Chemotherapy

Free access

Review article

First published 2010-6

CCR5 Antagonists: Host-Targeted Antiviral Agents for the Treatment of HIV Infection,4 Years on

Mike Westby, Elna van der Ryst

Antiviral Chemistry and Chemotherapy

Retricted access

Research article

First published 2005-12

The Development of an Europium-GTP Assay to Quantitate Chemokine Antagonist Interactions for CXCR4 and CCR5

Jean Labrecque, Virginia Anastassov, Gloria Lau [...]

ASSAY and Drug Development Technologies

Retricted access

Research article

First published 2011-10

Analyses of Anti-HIV Type 1 Activity of a Small CCR5 Peptide Antagonist

Fang Yu Wang, Shu Ya He, Zhi Jian Zhang [...]

AIDS Research and Human Retroviruses

Retricted access

Research article

First published 2010-01

HIV Type 1 from a Patient with Baseline Resistance to CCR5 Antagonists Uses Drug-Bound Receptor for Entry

John C. Tilton, Heather Amrine-Madsen, John L. Miamidian [...]

AIDS Research and Human Retroviruses

Retricted access

Research article

First published 2017-12

Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations,Variable Degrees of Resistance,and Minimal Cross-Resistance to Other CCR5 Antagonists

Jacqueline K. Flynn, Paula Ellenberg, Renee Duncan [...]

AIDS Research and Human Retroviruses

Open access

Review article

First published 2012

Maraviroc in Antiretroviral-Naïve HIV-1 Patients

Beniam Ghebremedhin

Infectious Diseases: Research and Treatment

Retricted access

Brief report

First published 2016-04

Reduced Frequencies and Activation of Regulatory T Cells After the Treatment of HIV-1-Infected Individuals with the CCR5 Antagonist Maraviroc Are Associated with a Reduction in Viral Loads Rather Than a Direct Effect of the Drug on Regulatory T Cells

Jara J. Joedicke, Miriam Dirks, Stefan Esser [...]

Viral Immunology

Free access

Research article

First published 2007-6

Investigating the Mechanistic Basis for Hepatic Toxicity Induced by an Experimental Chemokine Receptor 5 (CCR5) Antagonist Using a Compendium of Gene Expression Profiles

Paul D. Cornwell, Roger G. Ulrich

Toxicologic Pathology

Search results